These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

197 related articles for article (PubMed ID: 23388174)

  • 1. Diabetes and hypercholesterolemia increase blood-brain barrier permeability and brain amyloid deposition: beneficial effects of the LpPLA2 inhibitor darapladib.
    Acharya NK; Levin EC; Clifford PM; Han M; Tourtellotte R; Chamberlain D; Pollaro M; Coretti NJ; Kosciuk MC; Nagele EP; Demarshall C; Freeman T; Shi Y; Guan C; Macphee CH; Wilensky RL; Nagele RG
    J Alzheimers Dis; 2013; 35(1):179-98. PubMed ID: 23388174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Retinal pathology is associated with increased blood-retina barrier permeability in a diabetic and hypercholesterolaemic pig model: Beneficial effects of the LpPLA
    Acharya NK; Qi X; Goldwaser EL; Godsey GA; Wu H; Kosciuk MC; Freeman TA; Macphee CH; Wilensky RL; Venkataraman V; Nagele RG
    Diab Vasc Dis Res; 2017 May; 14(3):200-213. PubMed ID: 28301218
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Atherosclerotic plaque inflammation varies between vascular sites and correlates with response to inhibition of lipoprotein-associated phospholipase A2.
    Fenning RS; Burgert ME; Hamamdzic D; Peyster EG; Mohler ER; Kangovi S; Jucker BM; Lenhard SC; Macphee CH; Wilensky RL
    J Am Heart Assoc; 2015 Feb; 4(2):. PubMed ID: 25672369
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brain-reactive autoantibodies prevalent in human sera increase intraneuronal amyloid-β(1-42) deposition.
    Nagele RG; Clifford PM; Siu G; Levin EC; Acharya NK; Han M; Kosciuk MC; Venkataraman V; Zavareh S; Zarrabi S; Kinsler K; Thaker NG; Nagele EP; Dash J; Wang HY; Levitas A
    J Alzheimers Dis; 2011; 25(4):605-22. PubMed ID: 21483091
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Darapladib, a reversible lipoprotein-associated phospholipase A2 inhibitor, for the oral treatment of atherosclerosis and coronary artery disease.
    Riley RF; Corson MA
    IDrugs; 2009 Oct; 12(10):648-55. PubMed ID: 19790016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Abeta peptides can enter the brain through a defective blood-brain barrier and bind selectively to neurons.
    Clifford PM; Zarrabi S; Siu G; Kinsler KJ; Kosciuk MC; Venkataraman V; D'Andrea MR; Dinsmore S; Nagele RG
    Brain Res; 2007 Apr; 1142():223-36. PubMed ID: 17306234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evidence that Brain-Reactive Autoantibodies Contribute to Chronic Neuronal Internalization of Exogenous Amyloid-β1-42 and Key Cell Surface Proteins During Alzheimer's Disease Pathogenesis.
    Goldwaser EL; Acharya NK; Wu H; Godsey GA; Sarkar A; DeMarshall CA; Kosciuk MC; Nagele RG
    J Alzheimers Dis; 2020; 74(1):345-361. PubMed ID: 32039847
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A Chronic Increase in Blood-Brain Barrier Permeability Facilitates Intraneuronal Deposition of Exogenous Bloodborne Amyloid-Beta1-42 Peptide in the Brain and Leads to Alzheimer's Disease-Relevant Cognitive Changes in a Mouse Model.
    Acharya NK; Grossman HC; Clifford PM; Levin EC; Light KR; Choi H; Swanson Ii RL; Kosciuk MC; Venkataraman V; Libon DJ; Matzel LD; Nagele RG
    J Alzheimers Dis; 2024; 98(1):163-186. PubMed ID: 38393907
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Darapladib.
    Bui QT; Wilensky RL
    Expert Opin Investig Drugs; 2010 Jan; 19(1):161-8. PubMed ID: 20001561
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of lipoprotein-associated phospholipase A2 inhibitor on insulin resistance in streptozotocin-induced diabetic pregnant rats.
    Wang GH; Jin J; Sun LZ
    Endocr J; 2018 Sep; 65(9):903-913. PubMed ID: 29925744
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Darapladib for the treatment of cardiovascular disease.
    Campos CM; Suwannasom P; Koenig W; Serruys PW; Garcia-Garcia HM
    Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):33-48. PubMed ID: 25521799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of lipoprotein-associated phospholipase A2 reduces complex coronary atherosclerotic plaque development.
    Wilensky RL; Shi Y; Mohler ER; Hamamdzic D; Burgert ME; Li J; Postle A; Fenning RS; Bollinger JG; Hoffman BE; Pelchovitz DJ; Yang J; Mirabile RC; Webb CL; Zhang L; Zhang P; Gelb MH; Walker MC; Zalewski A; Macphee CH
    Nat Med; 2008 Oct; 14(10):1059-66. PubMed ID: 18806801
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Darapladib: an emerging therapy for atherosclerosis.
    Corson MA
    Ther Adv Cardiovasc Dis; 2010 Aug; 4(4):241-8. PubMed ID: 20660537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduction in Vasa Vasorum Angiogenesis by Lp-PLA2 Selective Inhibitor Through The HIF-1α and VEGF Expression Under Dyslipidemic Conditions in Atherosclerosis Pathogenesis.
    Heriansyah T; Nafisatuzzamrudah N; Aini FN; Ridwan M; Primardhika RF; Wijayanti M; Bekti RS; Wihastuti TA
    Cardiovasc Hematol Agents Med Chem; 2018; 16(2):114-119. PubMed ID: 30394217
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The effect of darapladib on plasma lipoprotein-associated phospholipase A2 activity and cardiovascular biomarkers in patients with stable coronary heart disease or coronary heart disease risk equivalent: the results of a multicenter, randomized, double-blind, placebo-controlled study.
    Mohler ER; Ballantyne CM; Davidson MH; Hanefeld M; Ruilope LM; Johnson JL; Zalewski A;
    J Am Coll Cardiol; 2008 Apr; 51(17):1632-41. PubMed ID: 18436114
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Method for measurement of the blood-brain barrier permeability in the perfused mouse brain: application to amyloid-beta peptide in wild type and Alzheimer's Tg2576 mice.
    LaRue B; Hogg E; Sagare A; Jovanovic S; Maness L; Maurer C; Deane R; Zlokovic BV
    J Neurosci Methods; 2004 Sep; 138(1-2):233-42. PubMed ID: 15325132
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of darapladib treatment on endarterectomy carotid plaque lipoprotein-associated phospholipase A2 activity: a randomized, controlled trial.
    Johnson JL; Shi Y; Snipes R; Janmohamed S; Rolfe TE; Davis B; Postle A; Macphee CH
    PLoS One; 2014; 9(2):e89034. PubMed ID: 24586490
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Serum-derived immunoglobulins neutralize adverse effects of amyloid-beta peptide on the integrity of a blood-brain barrier in vitro model.
    Poetsch V; Neuhaus W; Noe CR
    J Alzheimers Dis; 2010; 21(1):303-14. PubMed ID: 20421696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of AT1 receptors in permeability of the blood-brain barrier in diabetic hypertensive rats.
    Awad AS
    Vascul Pharmacol; 2006 Sep; 45(3):141-7. PubMed ID: 16959546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-Density Lipoprotein Mimetic Peptide 4F Efficiently Crosses the Blood-Brain Barrier and Modulates Amyloid-
    Swaminathan SK; Zhou AL; Ahlschwede KM; Curran GL; Lowe VJ; Li L; Kandimalla KK
    J Pharmacol Exp Ther; 2020 Nov; 375(2):308-316. PubMed ID: 32778535
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.